RAD51C and triple-negative breast carcinoma: In a patient with triple-negative breast cancer suspected of having germline variants in RAD51C, confirmatory testing by specific site analysis revealed pathological variants in RAD51C. Patients with suspected germline variants in BRCA1 were confirmed negative by BRAC Analysis.